Comments

Estrella Immunopharma Stock Price, Quotes and Forecasts

Q: What sector and industry does Estrella Immunopharma (ESLA) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ESLANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.9900

-0.04-3.88%

At close: -

$0.9500

-0.04-4.04%

After Hours: 9:14 AM EDT

Estrella Immunopharma (ESLA) Forecast

News Earnings Estrella Immunopharma (ESLA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Estrella Immunopharma Stock Price, Quotes and Forecasts | NASDAQ:ESLA | Benzinga

Explore Estrella Immunopharma stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ESLA.

Open	$1.03
Close	$0.99
Volume / Avg.	120.70K / 64.76K
Day Range	$0.97 - $1.03
52 Wk Range	0.63 - 3.23
Market Cap	$34.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.05%
Days to Cover	1

Recent News

This aTyr Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offering of common stock. DatChat shares dipped 33.1% to $2.13 in pre-market trading Here are some other stocks moving in pre-market trading.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.03
Close	$0.99
Volume / Avg.	120.70K / 64.76K
Day Range	$0.97 - $1.03
52 Wk Range	0.63 - 3.23
Market Cap	$34.37M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	41
Short Interest	0.05%
Days to Cover	1

About Estrella Immunopharma Inc

Sector

Health Care

Industry

Biotechnology

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-tar...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Estrella Immunopharma (ESLA) stock?

You can purchase shares of Estrella Immunopharma (NASDAQ:ESLA) through any online brokerage.

View our list of the best stock brokerages

Who are Estrella Immunopharma (ESLA) competitors?

Other companies in Estrella Immunopharma’s space includes: Kezar Life Sciences (NASDAQ:KZR), bluebird bio (NASDAQ:BLUE), Intensity Therapeutics (NASDAQ:INTS), Coeptis Therapeutics (NASDAQ:COEP) and FibroGen (NASDAQ:FGEN).

What is the forecast, or price target, for Estrella Immunopharma (ESLA) stock?

Estrella Immunopharma has a consensus price target of $16.00.

What is the current price for Estrella Immunopharma (ESLA)?

The stock price for Estrella Immunopharma (NASDAQ: ESLA) is $0.95 last updated March 3, 2025 at 9:14 AM EST.

Does Estrella Immunopharma (ESLA) pay a dividend?

There are no upcoming dividends for Estrella Immunopharma.

When is Estrella Immunopharma (NASDAQ:ESLA) reporting earnings?

Estrella Immunopharma’s Q3 earnings are confirmed for Wednesday, May 14, 2025.

Is Estrella Immunopharma (ESLA) going to split?

There is no upcoming split for Estrella Immunopharma.

What sector and industry does Estrella Immunopharma (ESLA) operate in?

Estrella Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.